EPISODE · Nov 16, 2021 · 28 MIN
Patient Advocacy in All Areas of Drug Development
from Applied Clinical Trials · host Applied Clinical Trials
Dr. Lise Lund Kjems, Chief Medical Officer at Cyclo Therapeutics, talks about Cyclo’s investigational therapy for Niemann-Pick Disease Type C and gives insight into rare disease drug development, with an emphasis on ensuring trial design includes holistic and specific patient concerns.
Embed this episode
Ready to play
Patient Advocacy in All Areas of Drug Development
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.